(Q40552167)

21 September 2017

title

Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children (English)

1 reference

21 September 2017

1 reference

tick-borne encephalitis

1 reference

tick-borne encephalitis vaccine

inferred from title

1 reference

2

1 reference

21 September 2017

Eder G

1

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

21 September 2017

1 reference

21 September 2017

volume

21

1 reference

21 September 2017

issue

25-26

1 reference

21 September 2017

page(s)

3575-3583

1 reference

The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Comparison of the epidemiological and clinical features of tick-borne encephalitis in children and adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Determinants of infant responses to vaccines in presence of maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Potential and pitfalls in the use of immunoassays for the quantification of live and inactivated virus using tick-borne encephalitis virus as a model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Response of infants to a third dose of poliomyelitis vaccine given 10 to 12 months after primary immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Simultaneous passive and active immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

The Vaccine Adverse Event Reporting System (VAERS)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Immunogenicity and reactogenicity of a highly purified vaccine against tick‐borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

Unexplained fever in neonates may be associated with hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900422-5

7 January 2021

10.1016/S0264-410X(03)00422-5

Identifiers

DOI

1 reference

21 September 2017

1 reference